Global Trends In Endothelial Cell Senescence Research In Cardiovascular Diseases: A Multi-Tool Bibliometric Analysis (2001-2024)
Cardiovascular diseases, which affect the heart and blood vessels, remain a leading cause of death worldwide. A key factor contributing to these conditions is the aging of endothelial cells, the specialized cells that line the inside of our blood vessels. When these cells age, a process known as senescence, they can stop functioning properly, leading to problems like stiff arteries and inflammation that contribute to heart disease. This area of research is crucial for understanding and combating age-related heart problems.
A recent study explored the global landscape of research into this specific topic over two decades, from 2001 to 2024. The aim was to understand who is leading the research, where it’s being published, and what the main focus areas and emerging trends are.
The analysis revealed a rapid increase in studies on endothelial cell senescence in cardiovascular diseases. Countries like China and the United States have been at the forefront, contributing nearly half of all published research. Prominent researchers and journals were identified, highlighting the key players in advancing this field.
Initially, much of the research focused on fundamental mechanisms, particularly the roles of “oxidative stress” (an imbalance between free radicals and antioxidants in the body) and “inflammation” (the body’s immune response) in endothelial cell aging. However, over time, there’s been a noticeable shift towards exploring how these discoveries can be applied to develop new treatments.
Despite this progress, the study also pointed out a significant challenge: there’s still a considerable gap between laboratory findings and their practical application in patient care. Looking ahead, the integration of advanced technologies like single-cell multi-omics (studying individual cells at a very detailed molecular level) and artificial intelligence could help bridge this gap, potentially accelerating the development of therapies that target senescent cells, known as senolytics, and other innovative treatments. This ongoing research is vital for developing new strategies to maintain healthy blood vessels and prevent cardiovascular diseases as we age.
Source: link to paper